Skip to main content
. 2022 Jan 7;6(1):189–199. doi: 10.1182/bloodadvances.2021005354

Table 2.

MYD88L265P presence among patients with IgM monoclonal gammopathies

Mutation rate (%) IgM-MGUS (n = 53) aWM (n = 54) sWM (n = 56)
tDNA 89% (33/37) 97% (32/33) 92% (36/39)
cfDNA 80% (41/51) 82% (37/45) 93% (44/47)